Calypso Biotech is a biopharmaceuticals company that discovers and develops novel therapies for auto-immune diseases.
| Website | http://www.calypsobiotech.com |
| Revenue | $8 million |
| Employees | 11 (2 on RocketReach) |
| Founded | 2013 |
| Phone | +41 22 552 33 07 |
| Technologies |
JavaScript
,
HTML
,
PHP
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| Web Rank | 8 Million |
| Keywords | Autoimmune Diseases, Autoimmune Treatment, Drug Discovery, Therapeutic Development, Drug Development, Novel Therapies, Pharmaceutical Research, Immunology, Immunotherapy, Biotechnology, Biologics, Pharmaceutical, Clinical Trials, Preclinical Studies, Disease Treatment, Biotech, Life Sciences, Healthcare, Medicine |
| Competitors | Roche, Pfizer, Amgen, Novartis, AbbVie, Genentech, Biogen, Mylan Belgium, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +49 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular Calypso Biotech employee's phone or email?
The Calypso Biotech annual revenue was $8 million in 2026.
Jos Houbiers is the Chief Medical Officer of Calypso Biotech.
2 people are employed at Calypso Biotech.
The NAICS codes for Calypso Biotech are [5417, 54, 54171, 541713, 541].
The SIC codes for Calypso Biotech are [873, 87].